| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |